Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myPHteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
September 4, 2024
 · 
Reactions
What Is Pulmonary Arterial Hypertension (PAH)? Read Article...
myPHteam

The combination of tadalafil (Adcirca) and ambrisentan (Letairis) has been shown to improve symptoms of pulmonary arterial hypertension (PAH), including shortness of breath. According to my knowledge base:

- Symptom Improvement: Studies have shown that dual therapy helps improve PAH symptoms by lowering mean pulmonary Show Full Answer

The combination of tadalafil (Adcirca) and ambrisentan (Letairis) has been shown to improve symptoms of pulmonary arterial hypertension (PAH), including shortness of breath. According to my knowledge base:

- Symptom Improvement: Studies have shown that dual therapy helps improve PAH symptoms by lowering mean pulmonary arterial pressure.
- Exercise Capacity: Many people also see improvements in their exercise capacity and 6-minute walk distance (6MWD) from the 6-minute walk test.

While the exact time frame for symptom improvement can vary, these benefits are generally observed over the course of treatment. Your healthcare provider will monitor your progress and adjust treatment as needed.

September 4, 2024

Related Questions

View All
A myPHteam Member asked a question 💭
Lubbock, TX

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In